Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome

Journal of Steroid Biochemistry and Molecular Biology

Volumn 61, Issue 1-2, 1997, Pages 19-26

  Bevan, Charlotte L ^a,b   Hughes, Ieuan A ^a   Patterson, Mark N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; MIBOLERONE;

ANDROGEN INSENSITIVITY SYNDROME; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN COS1; CLINICAL ARTICLE; GENE CONSTRUCT; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIGAND BINDING; MALE; MAMMAL CELL; MUTATION; NONHUMAN; PHENOTYPE; RECEPTOR BINDING; SEX DIFFERENTIATION; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; COS CELLS; HELA CELLS; HUMANS; KINETICS; LIGANDS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; NANDROLONE; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SEX DIFFERENTIATION DISORDERS; TESTOSTERONE CONGENERS; TRANS-ACTIVATION (GENETICS);

ANIMALIA; MAMMALIA;

EID: 0030800489     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00001-0     Document Type: Article

References (52)

1. Wilson J. D., Griffin J. E., George F. W. and Leshin M.: The role of gonadal steroids in sexual differentiation. Recent Progr. Horm. Res. 37 (1981) 1-39.
2. Patterson, M. N., McPhaul, M. J. and Hughes, I. A.: Androgen insensitivity syndrome. In Bailliere's Clinical Endocrinology and Metabolism, Vol. 8, eds M. C. Sheppard and P. M. Stewart. Balliere Tindall, London, 1994, pp. 379-404.
3. Quigley C., De Bellis A., Marschke K., El-Awady M., Wilson E. and French F.: Androgen receptor defects: historical, clinical and molecular perspectives. Endocr. Rev. 16 (1995) 271-321.
4. Bale P. M., Howard N. J. and Wright J. E.: Male pseudohermaphroditism in XY children with female phenotype. Pedr. Pathol. 12 (1991) 29-49.
5. Rutgers J. and Scully R.: The androgen insensitivity syndrome (testicular feminisation): a clinicopathologic study of 43 cases. Int. J. Gynecol. Pathol. 10 (1991) 126-144.
6. Jukier L., Kaufman M., Pinsky L. and Peterson R. E.: Partial androgen resistance associated with a secondary 5α-reductase deficiency: identification of a novel qualitative androgen receptor defect and clinical implications. J. Clin. Endocr. Metab. 59 (1984) 679-688.
7. Quigley C., Friedman K. J., Johnson A., Lafreniere R. G., Silverman L. M., Lubahn D. B., Brown T. R., Wilson E. M., Willard H. F. and French F. S.: Complete deletion of the androgen receptor: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. Clin. Endocr. Metab. 74 (1992) 927-933.
8. Lubahn D. B., Joseph D. R., Sullivan P. M., Willard H. F., French F. S. and Wilson E. M.: Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240 (1988) 327-330.
9. Chang C., Kokontis J. and Liao S.: Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240 (1988) 324-326.
10. Trapman J., Klaasen P., Kuiper G. G. J. M., van der Korput J. A. C. M., Faber P. W., van Rooij H. C. J., Geurts van Kessel A., Voorhorst M. M., Mulder E. and Brinkmann A. O.: Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem. Biophys. Res. Commun. 153 (1988) 241-248.
11. Tsai M.-J. and O'Malley B.: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486.
12. Lubahn D. B., Brown T. R., Simental J. A., Higgs H. N., Migeon C. J., Wilson E. M. and French F. S.: Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9534-9538.
13. Brinkmann A. O., Faber P. W., van Rooij H. C. J., Kuiper G. G. J. M., Ris C., Klaasen P., van der Korput J. A. G. M., Voorhorst M. M., van Laar J. H., Mulder E. and Trapman J.: The human androgen receptor: domain structure, genomic organisation and regulation of expression. J. Steroid Biochem. 34 (1989) 307-310.
14. Jenster G., van der Korput H., Trapman J. and Brinkmann A. O.: Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J. Steroid Biochem. Molec. Biol. 53 (1995) 443-448.
15. Freedman L.: Anatomy of the steroid receptor zinc finger region. Endocr. Rev. 13 (1992) 129-145.
16. Zhou Z.-X., Sar M., Simental J. A., Lane M. V. and Wilson E. M.: A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. J. Biol. Chem. 269 (1994) 13115-13123.
17. Jenster G., Trapman J. and Brinkmann A. O.: Nuclear import of the human androgen receptor. Biochem. J. 293 (1993) 761-768.
18. Gast A., Neuschmid-Kaspar F., Klocker H. and Cato A. C.: A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome. Molec. Cell. Endocr. 111 (1995) 93-98.
19. Nemoto T., OharaNemoto Y., Shimazaki S. and Ota M.: Dimerization characteristics of the DNA-and steroid-binding domains of the androgen receptor. J. Steroid Biochem. Molec. Biol. 50 (1994) 225-233.
20. Fawell S. E., Lees J. A., White R. and Parker M. G.: Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60 (1990) 953-962.
21. Simental J. A., Sar M., Lane M. V., French F. S. and Wilson E. M.: Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266 (1991) 510-518.
22. Danielian P. S., White R., Lees J. A. and Parker M. G.: Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11 (1992) 1025-1033.
23. Wurtz J.-M., Bourguet W., Renaud J.-P., Vivat V., Chambon P., Moras D. and Gronemeyer H.: A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol. 3 (1996) 87-94.
24. Yeh S. Y. and Chang C. S.: Cloning and characterization of a specific coactivator, ARA(70), for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5517-5521.
25. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P. J. and Parker M. G.: Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14 (1995) 3741-3751.
26. Oñate S. A., Tsai S. Y., Tsai M.-J. and O'Malley B. W.: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357.
27. vom Baur E., Zechel C., Heery D., Heine M. J., Garnier J. M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P. and Losson R.: Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15 (1996) 110-124.
28. Gottlieb B., Trifiro M., Lumbroso R., Vasiliou D. M. and Pinsky L.: The androgen receptor gene-mutations database. Nud. Acids Res. 24 (1996) 151-154.
29. Bevan C. L., Brown B. D., Davies H. R., Evans B. A., Hughes I. A. and Patterson M. N.: Functional analysis of six androgen receptor mutations identified in patients with partial androgen insensitivity syndrome. Hum. Molec. Gen. 5 (1996) 265-273.
30. Batch J. A., Williams D. M., Davies H. R., Brown B., Evans B. A. J., Hughes I. A. and Patterson M. N.: Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum. Molec. Genet. 1 (1992) 497-503.
31. Patterson M. N., Davies H. R. and Hughes I. A.: Detection of androgen receptor gene mutations in AIS patients by semi-automated DNA sequence analysis. J. Cell. Biochem. 18B (Suppl.) (1994) 396.
32. Lubahn D. B., Joseph D. R., Sar M., Tan J., Higgs H. N., Larson R. E., French F. S. and Wilson E. M.: The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Molec. Endocr. 2 (1988) 1265-1275.
33. Hanahan D.: Studies on transformation of Escherichia coli with plasmids. J. Molec. Biol. 166 (1983) 557-580.
34. Chomczynski P. and Sacchi N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162 (1987) 156-159.
35. Ausubel, F., Brent, R., Kingston, R., Moore, D., Seidman, J., Smith, J. and Struhl, K.: Current protocols on CD-ROM. In Current Protocols on CD-ROM, ed. K. Janssen. Greene Publishing Associates Inc. and John Wiley and Sons Inc., New York, 1995.
36. Sambrook, J., Fritsch, E. F. and Maniatis, T. S.: Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989.
37. Shule R., Muller M., Kaltschmidt C. and Renkawitz R.: Many transcription factors interact synergistically with steroid receptors. Science 242 (1988) 1418-1420.
38. Mizushima S. and Nagata S.: pEF-BOS, a powerful mammalian expression vector. Nucl. Acids Res. 18 (1990) 5322.
39. van Laar J. H., Voorhorst-Ogink M. M., Zegers N. D., Boersma W. J. A., Claassen E., van der Korput J. A. G. M., Ruizeveld de Winter J. A., van der Kwast T. H., Mulder E., Trapman J. and Brinkmann A. O.: Characterisation of polyclonal antibodies against the N-terminal domain of the human androgen receptor. Molec. Cell Endocr. 67 (1939) 29-38.
40. Schüle R., Muller M., Kaltschmidt C. and Renkawitz R.: Many transcription factors interact synergistically with steroid receptors. Science 242 (1988) 1418-1420.
41. Murono, K., Migeon, C. J. and Brown, T. R.: Functional study of mutant androgen receptors. In Proceedings of the 28th Annual Meeting of the Japanese Society for Pediatric Endocrinology, (Abstract 8), 1995, p. 57.
42. de Bellis A., Quigley C. A., Cariello N. F., El-Awady M. F., Sar M., Lane M. V., Wilson E. M. and French F. S.: Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique. Molec. Endocr. 6 (1992) 1909-1920.
43. Shkolny D. L., Brown T. R., Punnett H. H., Kaufman M., Trifiro M. A. and Pinsky L.: Characterization of amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families. Hum. Molec. Genet. 4 (1995) 515-521.
44. Marcelli M., Zoppi S., Wilson C., Griffin J. and McPhaul M.: Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex. J. Clin. Invest. 94 (1994) 1642-1650.
45. Brown T. R., Lubahn D. B., Wilson E. M., French F. S., Migeon C. J. and Corden J. L.: Functional characterisation of naturally occurring mutant androgen receptors from patients with complete androgen insensitivity. Molec. Endocr. 4 (1990) 1759-1772.
46. Kazemi-Esfarjani P., Beitel L. K., Trifiro M., Kaufman M., Rennie P., Sheppard P., Matusik R. and Pinsky L.: Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes. Molec. Endocr. 7 (1993) 37-46.
47. Kaspar F., Cato A., Denninger A., Eberle J., Radmayr C., Glatzl J., Bartsch G. and Klocker H.: Characterization of two point mutations in the androgen receptor gene of patients with perineoscrotal hypospadia. J. Steroid Biochem. Molec. Biol. 47 (1993) 127-135.
48. Bourguet W., Ruff M., Chambon P., Gronemeyer H. and Moras D.: Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375 (1995) 377-382.
49. Jenster G., van der Korput H. A. G. M., van Vroonhoven C., van der Kwast T. H., Trapman J. and Brinkmann A. O.: Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Molec. Endocr. 5 (1991) 1396-1404.
50. Choong C. S., Sturm M. J., Strophair J. A., McCulloch R. K., Tilley W. D., Leedman P. J. and Hurley D. M.: Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly>Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels. J. Clin. Endocr. Metab. 81 (1996) 236-243.
51. Zhou Z.-X., Lane M. V., Kemppainen J. A., French F. S. and Wilson E. M.: Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Molec. Endocr. 9 (1995) 208-218.
52. Renaud J.-P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H. and Moras D.: Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378 (1995) 681-689.